Cross-sectional evaluation of noninvasively detected skin intrinsic fluorescence and mean hemoglobin a1c in type 1 diabetes
- PMID: 23305087
- PMCID: PMC3558674
- DOI: 10.1089/dia.2012.0211
Cross-sectional evaluation of noninvasively detected skin intrinsic fluorescence and mean hemoglobin a1c in type 1 diabetes
Abstract
Background: This study evaluated the relationship between skin intrinsic fluorescence (SIF) and long-term mean hemoglobin A1c (HbA1c) in individuals with type 1 diabetes.
Subjects and methods: We undertook a cross-sectional analysis of 172 individuals with type 1 diabetes followed longitudinally with HbA1c data available over an average of 16.6 years. SIF was evaluated cross-sectionally using the SCOUT DS device (VeraLight Inc., Albuquerque, NM) and correlated with most recent HbA1c and long-term mean HbA1c. Potential determinants of this relationship, including age, gender, smoking status, duration of diabetes, and renal function, were also evaluated.
Results: Age-adjusted skin intrinsic fluorescence significantly correlated with long-term mean HbA1c (R=0.44, P<0.0001). In contrast, there was no significant relationship between SIF and most recent HbA1c (R=0.14, P=0.075). The best-fit model describing the relationship between SIF and mean HbA1c controlled for factors of age, duration of disease, renal function, and site of study conduct. Controlling for these factors was also important in understanding the relationship between most recent HbA1c and SIF. Evaluating longer-term HbA1c data also strengthened the relationship between SIF and mean HbA1c. In the presence of renal dysfunction or damage, as indicated by an estimated glomerular filtration rate of <60 mL/min/1.73 m2 or presence of gross proteinuria, there was no significant correlation between SIF and mean HbA1c.
Conclusions: Noninvasive detection of SIF significantly correlates with long-term mean HbA1c, providing insight into long-term glycemic exposure. Age, duration of diabetes, and renal function are potential contributors to this relationship.
Figures
Similar articles
-
Predictors of Change in Skin Intrinsic Fluorescence in Type 1 Diabetes: The Epidemiology of Diabetes Complications Study.J Diabetes Sci Technol. 2021 Nov;15(6):1368-1376. doi: 10.1177/19322968211014337. Epub 2021 May 15. J Diabetes Sci Technol. 2021. PMID: 33993770 Free PMC article.
-
Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.Diabetes Technol Ther. 2013 Jun;15(6):466-74. doi: 10.1089/dia.2012.0316. Diabetes Technol Ther. 2013. PMID: 23882708 Free PMC article. Clinical Trial.
-
Skin intrinsic fluorescence is associated with hemoglobin A(1c )and hemoglobin glycation index but not mean blood glucose in children with type 1 diabetes.Diabetes Care. 2011 Aug;34(8):1816-20. doi: 10.2337/dc11-0049. Epub 2011 Jun 2. Diabetes Care. 2011. PMID: 21636794 Free PMC article.
-
Glycated hemoglobin. Reaction and biokinetic studies. Clinical application of hemoglobin A1c in the assessment of metabolic control in children with diabetes mellitus.Dan Med Bull. 1985 Dec;32(6):309-28. Dan Med Bull. 1985. PMID: 3908003 Review.
-
The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes.Glycoconj J. 2016 Aug;33(4):569-79. doi: 10.1007/s10719-016-9702-2. Epub 2016 Jun 25. Glycoconj J. 2016. PMID: 27342131 Free PMC article. Review.
Cited by
-
Advanced glycation end products are not associated with bone mineral density, trabecular bone score, and bone turnover markers in adults with and without type 1 diabetes: a cross-sectional study.JBMR Plus. 2024 Jan 4;8(3):ziad018. doi: 10.1093/jbmrpl/ziad018. eCollection 2024 Feb. JBMR Plus. 2024. PMID: 38505219 Free PMC article.
-
Skin Autofluorescence - A Non-invasive Measurement for Assessing Cardiovascular Risk and Risk of Diabetes.Eur Endocrinol. 2014 Aug;10(2):106-110. doi: 10.17925/EE.2014.10.02.106. Epub 2014 Aug 28. Eur Endocrinol. 2014. PMID: 29872473 Free PMC article. Review.
-
Predictors of Change in Skin Intrinsic Fluorescence in Type 1 Diabetes: The Epidemiology of Diabetes Complications Study.J Diabetes Sci Technol. 2021 Nov;15(6):1368-1376. doi: 10.1177/19322968211014337. Epub 2021 May 15. J Diabetes Sci Technol. 2021. PMID: 33993770 Free PMC article.
-
Lifestyle and clinical determinants of skin autofluorescence in a population-based cohort study.Eur J Clin Invest. 2016 May;46(5):481-90. doi: 10.1111/eci.12627. Epub 2016 Apr 15. Eur J Clin Invest. 2016. PMID: 27002914 Free PMC article.
-
Skin intrinsic fluorescence scores are a predictor of all-cause mortality risk in type 1 diabetes: The Epidemiology of Diabetes Complications study.J Diabetes Complications. 2021 Feb;35(2):107770. doi: 10.1016/j.jdiacomp.2020.107770. Epub 2020 Oct 23. J Diabetes Complications. 2021. PMID: 33168396 Free PMC article.
References
-
- The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977–986. - PubMed
-
- Reiser KM. Nonenzymatic glycation of collagen in aging and diabetes. Proc Soc Exp Biol Med. 1991;196:17–29. - PubMed
-
- Verzijl N. DeGroot J. Thorpe SR. Bank TA. Shaw JN. Lyons TJ. Bijlsma JW. Lafeber FP. Baynes JW. TeKoppele JM. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem. 2000;50:39027–39031. - PubMed
-
- Monnier VM. Bautista O. Kenny D. Sell DR. Fogarty J. Dahms W. Cleary PA. Lachin J. Genuth S. Skin collagen glycation, glycoxidation, crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes. 1999;48:870–880. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical